Previous 10 | Next 10 |
Destination Maternity (NASDAQ: DEST ): Q4 Non-GAAP EPS of -$0.31; GAAP EPS of -$0.46. More news on: Destination Maternity Corporation, Earnings news and commentary, Consumer stocks news, , Read more ...
- Operating loss of $9.6 million for fiscal 2018 versus an operating loss of $16.0 million in 2017 - Adjusted EBITDA before other charges for fiscal 2018 increases 23% or $3.0 million versus 2017 - Comparable retail sales for fiscal 2018 decline 1.8% versus 2017 - Selling, General a...
Destination Maternity Corporation (Nasdaq: DEST) today announced its fourth quarter fiscal 2018 financial results will take place on Tuesday, April 16, 2019. Results will be released at approximately 6:45 a.m. Eastern Time. Members of its senior management will hold a conference call at 9:00...
- Announces Departure of Current Board Member Andrea J.Funk - Destination Maternity Corporation (NASDAQ:DEST), the world's leading maternity apparel retailer, today announced that it has appointed Greg Kleffner to the Board of Directors (the “Board”), effective March 29,...
Gainers: Seelos Therapeutics (NASDAQ: SEEL ) +40% . Hibbett Sports (NASDAQ: HIBB ) +23% . Bio-Path Holdings (NASDAQ: BPTH ) +18% . Immutep (NASDAQ: IMMP ) +17% . CounterPath (NASDAQ: CPAH ) +12% . Destination Maternity (NASDAQ: DEST ) +11% . Netshoes (NYSE: NETS ) +11% . AC Im...
– Announces Departure of Current Board Member Holly Alden – Destination Maternity Corporation (NASDAQ: DEST), the world's leading maternity apparel retailer, today announced that it has appointed Lisa Gavales to the Board of Directors (the “Board”), effecti...
Editor's note: Seeking Alpha is proud to welcome Fund Letter Stock Ideas as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » ...
This article is part of a series that provides an ongoing analysis of the changes made to Prem Watsa’s 13F portfolio on a quarterly basis. It is based on Watsa’s regulatory 13F Form filed on 02/14/2019. Please visit our Tracking Prem Watsa’s Fairfax Financial Holdings P...
Original Post Choice Equities Fund commentary for the fourth quarter ended December 31, 2018, discussing their new potions in Under Armour ([[UA]]) and Rubicon Project ([[RUBI]]). Dear Investor: We are pleased to report strong absolute and relative performance for Choice Equities Fun...
InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...
News, Short Squeeze, Breakout and More Instantly...
Destination Maternity Corporation Company Name:
DEST Stock Symbol:
NASDAQ Market:
Destination Maternity Corporation Website:
(NewsDirect) Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) CEO Neil Clark speaks to Proactive after releasing fresh data from the update from a research collaboration into a novel biotherapeutic treatment for COVID-19 and influenza. Clark says that the project has already delivered "more than ...
(NewsDirect) Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) CEO Neil Clark speaks to Thomas Warner from Proactive after releasing the clinical-stage biotechnology company's full year results for 2022. Clark says that Destiny Pharma is focused on finding a partner for its lead asset, XF-73, ...
(NewsDirect) Destiny Pharma PLC (AIM:DEST, OTC:DTTYF) chief scientific officer Bill Love speaks to Proactive after results from a study into its C. Difficile treatment platform NTCD-M3 were published in the Microbiology Spectrum journal. Love explains what makes the platform so promis...